PALI
Palisade Bio IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$338.87M
P/E Ratio
16.25
EPS
$0.12
Beta
1.53
52W High
$2.86
52W Low
$0.53
50-Day MA
$2.00
200-Day MA
$1.68
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Palisade Bio Inc
Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. The company is headquartered in Carlsbad, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-26.49M |
| Operating Margin | 0.00% |
| Return on Equity | -36.40% |
| Return on Assets | -23.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.76 |
| Price-to-Book | 2.67 |
| Price-to-Sales (TTM) | 11.78 |
| EV/Revenue | 234.89 |
| EV/EBITDA | 0.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $173.58M |
| Float | $128.36M |
| % Insiders | 0.03% |
| % Institutions | 88.07% |
Historical Volatility
HV 10-Day
62.40%
HV 20-Day
73.15%
HV 30-Day
102.50%
HV 60-Day
89.47%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($9.71 target)
2
Strong Buy5
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026